You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

METOPROLOL SUCCINATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Metoprolol Succinate patents expire, and when can generic versions of Metoprolol Succinate launch?

Metoprolol Succinate is a drug marketed by Accord Hlthcare, Actavis Elizabeth, Actavis Labs Fl Inc, Alkem Labs Ltd, Cipla, Dr Reddys Labs Ltd, Granules, Hetero Labs Ltd Iii, Lupin, Mylan Pharms Inc, Nesher Pharms, Novast Labs, Pharmadax Inc, Prinston Inc, Reddys, Sandoz, Sunshine, Visum Pharm, Wockhardt, Yichang Humanwell, Zhejiang Jutai Pharm, and Zydus Pharms. and is included in twenty-seven NDAs.

The generic ingredient in METOPROLOL SUCCINATE is metoprolol succinate. There are sixty drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Metoprolol Succinate

A generic version of METOPROLOL SUCCINATE was approved as metoprolol succinate by ACTAVIS LABS FL INC on August 3rd, 2009.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for METOPROLOL SUCCINATE?
  • What are the global sales for METOPROLOL SUCCINATE?
  • What is Average Wholesale Price for METOPROLOL SUCCINATE?
Drug patent expirations by year for METOPROLOL SUCCINATE
Drug Prices for METOPROLOL SUCCINATE

See drug prices for METOPROLOL SUCCINATE

Drug Sales Revenue Trends for METOPROLOL SUCCINATE

See drug sales revenues for METOPROLOL SUCCINATE

Recent Clinical Trials for METOPROLOL SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and DevelopmentPhase 3
CytokineticsPhase 3
Yang I. PachankisPhase 4

See all METOPROLOL SUCCINATE clinical trials

Pharmacology for METOPROLOL SUCCINATE
Anatomical Therapeutic Chemical (ATC) Classes for METOPROLOL SUCCINATE

US Patents and Regulatory Information for METOPROLOL SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 090615-003 Jul 22, 2010 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Pharms Inc METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 202033-004 Dec 15, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd Iii METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 205541-003 Nov 6, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.